Top Abstract Purchase Related
Home
>
Node
>
Subnode

Cladribine (2-chloro-2'-deoxyadenosine) : new perspectives in clinical immunosuppression

Górski, A.; Grieb, P.

Archivum Immunologiae et Therapiae Experimentalis 42(1): 11-12

1994

ISSN/ISBN: 0004-069X
PMID: 7503626
Document Number: 436697
Cladribine (2-chloro-2'-deoxyadenosine) has been recently introduced in the treatment of hematologic malignancies. We have shown that CdA has potent inhibitory activity in vitro and in vivo in concentrations readily achievable in the sera of treated patients. The immunosuppressive efficacy of CdA was at least equal to that of cyclosporine. Furthermore, CdA is particularly efficacious inhibitor of B cell activation.

Document emailed within 1 workday
Secure & encrypted payments

Grieb, P. 1994: Discovery, mechanism and expected clinical significance of selective cytotoxicity of 2-chloro-2'-deoxyadenosine (2-CdA) Archivum Immunologiae et Therapiae Experimentalis 42(1): 1-5
Tarasiuk, A.; Skierski, J.; Kazimierczuk, Z. 1994: Stability of 2-chloro-2'-deoxyadenosine at various pH and temperature Archivum Immunologiae et Therapiae Experimentalis 42(1): 13-15
Ding, K.H.; Liang, N.C. 1995: Inhibition of 5'-chloro-5'-deoxyadenosine on phosphoinositide and protein phosphorylation in swine platelets Zhongguo Yao Li Xue Bao 16(3): 247-250
Filleul, B.; Delannoy, A.; Ferrant, A.; Zenebergh, A.; Van Daele, S.; Bosly, A.; Doyen, C.; Mineur, P.; Glorieux, P.; Driesschaert, P. 1994: A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission Leukemia 8(7): 1153-1156
Conrad, D.M.; Robichaud, M.R.J.; Mader, J.S.; Boudreau, R.T.M.; Richardson, A.M.; Giacomantonio, C.A.; Hoskin, D.W. 2008: 2-Chloro-2'-deoxyadenosine-induced apoptosis in T leukemia cells is mediated via a caspase-3-dependent mitochondrial feedback amplification loop International Journal of Oncology 32(6): 1325-1333
Jäger, G.; Höfler, G.; Linkesch, W.; Neumeister, P. 2004: Occurrence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literature Haematologica 89(4): Ecr01
Kumagai, M.; Manabe, A.; Coustan-Smith, E.; Blakley, R.L.; Beck, W.T.; Santana, V.M.; Behm, F.G.; Raimondi, S.C.; Campana, D. 1994: Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemia Leukemia 8(7): 1116-1123
Góra-Tybor, J.; Robak, T. 1996: Clinical pharmacology of 2-chlorodeoxyadenosine (Cladribine) Przeglad Lekarski 53(8): 614-618
Selvaggi, G.; Ricordi, C.; Bottino, R.; Tzakis, A.G. 1996: Liver transplantation without immunosuppression: future perspectives Italian Journal of Gastroenterology 28(4): 246-249
Brzozowski, Z.; Angielski, S.; Jakubowski, Z. 1977: Derivatives of 4-chloro-5-sulfamylbenzoic acid. II. Synthesis and diuretic activity of 5-chloro-2-carboxy-4-sulfamylphenyl hydrazones of various aldehydes and ketones Acta Poloniae Pharmaceutica 34(1): 33-37
Kojima, T.; Fukumoto, H. 1970: Chloro-biphenyls poisoning. Chloro-biphenyls in the biological material Nihon Hoigaku Zasshi 24(4): 314-318
Parker, W.B.; Shaddix, S.C.; Rose, L.M.; Shewach, D.S.; Hertel, L.W.; Secrist, J.A.; Montgomery, J.A.; Bennett, L.L. 1999: Comparison of the mechanism of cytotoxicity of 2-chloro-9-(2-deoxy-2- fluoro-beta-D-arabinofuranosyl)adenine, 2-chloro-9-(2-deoxy-2-fluoro- beta-D-ribofuranosyl)adenine, and 2-chloro-9-(2-deoxy-2,2-difluoro- beta-D-ribofuranosyl)adenine in CEM cells Molecular Pharmacology 55(3): 515-520
Castillo Lugo, J.A. 1995: Clinical and experimental immunosuppression Boletin de la Asociacion Medica de Puerto Rico 87(5-6): 106-108
Baltz, J.K.; Montello, M.J. 1993: Cladribine for the treatment of hematologic malignancies Clinical Pharmacy 12(11): 805
Aurer, I.; Mitrović, Z.; Kovacević-Metelko, J.; Radman, I.; Basić-Kinda, S.; Gjadrov-Kuvezdić, K.; Jakić-Razumović, J.; Dubravcić, K.; Ries, S.; Nola, M.; Zupancic-Salek, S.; Labar, B. 2007: Treatment of hairy cell leukemia with cladribine Lijecnicki Vjesnik 129(3-4): 80-83
Robles-Cedeno, R.; Ramio-Torrenta, L. 2018: Cladribine in the treatment of relapsing multiple sclerosis Revista de Neurologia 67(9): 343-354
Yang, M.H.; Ho, C.H. 2001: 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia Zhonghua Yi Xue Za Zhi 64(1): 54-58
Guttmann, R.D. 1994: Clinical immunosuppression, lymphocyte subsets, and host defense mechanisms Transplantation Proceedings 26(4): 1847
Agarwal, D.; Chakravarty, J.; Sundar, S.; Gupta, V.; Bhatia, B.D. 2008: Correlation between clinical features and degree of immunosuppression in HIV infected children Indian Pediatrics 45(2): 140-143
Dewilde, A. 2002: Virus and immunosuppression. 3d Seminar on Clinical Virology, Nancy, October 11 and 12, 2001 Annales de Biologie Clinique 60(4): 485-498